Saved in:
Bibliographic Details
Main Authors: Mamajonova Mazmunaxon Masrurjon qizi, Xodjayeva Muqaddas Sati- Maxamatovna, Worldly Knowledge Publishing Centre
Format: Recurso digital
Language:
Published: Zenodo 2026
Online Access:https://doi.org/10.5281/zenodo.18599936
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866901949949935616
author Mamajonova Mazmunaxon Masrurjon qizi
Xodjayeva Muqaddas Sati- Maxamatovna
Worldly Knowledge Publishing Centre
author_facet Mamajonova Mazmunaxon Masrurjon qizi
Xodjayeva Muqaddas Sati- Maxamatovna
Worldly Knowledge Publishing Centre
contents <p>Lekanemab va donanemab kabi miyadagi beta-amiloidni nishonga oluvchi monoklonal antitanachalar (MAT) kasallikning erta bosqichidagi bemorlarda kognitiv pasayishni sekinlashtirib, Alzgeymer kasalligini davolashda patogenetik (kasallikni o‘zgartiruvchi) yangi davrni boshlab berdi. AQSH oziq-ovqat va farmatsevtika idorasi (FDA) tomonidan tasdiqlangan ushbu terapiyalar immunoterapiya orqali amiloid g’umbaklarini tozalaydi va an’anaviy simptomatik dori vositalaridan farqli o‘laroq, yangicha yondashuvni taklif etadi. Biroq, ular miya shishishi yoki qon quyilishi (ARIA) kabi xavflar bilan birga kechadi.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_18599936
institution Zenodo
language
publishDate 2026
publisher Zenodo
record_format zenodo
spellingShingle MONOKLONAL ANTITANACHALAR: ALZGEYMER KASALLIGINI DAVOLASHDAGI YANGI DAVR
Mamajonova Mazmunaxon Masrurjon qizi
Xodjayeva Muqaddas Sati- Maxamatovna
Worldly Knowledge Publishing Centre
<p>Lekanemab va donanemab kabi miyadagi beta-amiloidni nishonga oluvchi monoklonal antitanachalar (MAT) kasallikning erta bosqichidagi bemorlarda kognitiv pasayishni sekinlashtirib, Alzgeymer kasalligini davolashda patogenetik (kasallikni o‘zgartiruvchi) yangi davrni boshlab berdi. AQSH oziq-ovqat va farmatsevtika idorasi (FDA) tomonidan tasdiqlangan ushbu terapiyalar immunoterapiya orqali amiloid g’umbaklarini tozalaydi va an’anaviy simptomatik dori vositalaridan farqli o‘laroq, yangicha yondashuvni taklif etadi. Biroq, ular miya shishishi yoki qon quyilishi (ARIA) kabi xavflar bilan birga kechadi.</p>
title MONOKLONAL ANTITANACHALAR: ALZGEYMER KASALLIGINI DAVOLASHDAGI YANGI DAVR
url https://doi.org/10.5281/zenodo.18599936